Management of infections in cirrhotic patients: Report of a Consensus Conference
Abstract The statements produced by the consensus conference on infection in end-stage liver disease promoted by the Italian Association for the Study of the Liver, are here reported. The topics of epidemiology, risk factors, diagnosis, prophylaxis, and treatment of infections in patient with compen...
Gespeichert in:
| Veröffentlicht in: | Digestive and liver disease 2014-03, Vol.46 (3), p.204-212 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 212 |
|---|---|
| container_issue | 3 |
| container_start_page | 204 |
| container_title | Digestive and liver disease |
| container_volume | 46 |
| creator | Fagiuoli, Stefano Colli, Agostino Bruno, Raffaele Burra, Patrizia Craxì, Antonio Gaeta, Giovan Battista Grossi, Paolo Mondelli, Mario U Puoti, Massimo Sagnelli, Evangelista Stefani, Stefania Toniutto, Pierluigi |
| description | Abstract The statements produced by the consensus conference on infection in end-stage liver disease promoted by the Italian Association for the Study of the Liver, are here reported. The topics of epidemiology, risk factors, diagnosis, prophylaxis, and treatment of infections in patient with compensated and decompensated liver cirrhosis were reviewed by a scientific board of experts who proposed 26 statements that were graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. By systematic literature search of available evidence, comparison and discussion of expert opinions, pertinent statements answering specific questions were presented and approved. Short comments were added to explain the basis for grading evidence particularly on case of controversial areas. |
| doi_str_mv | 10.1016/j.dld.2013.07.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1511823293</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1590865813002582</els_id><sourcerecordid>1511823293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-71ae80647abcb0f4a6458c679f6e266924d452bdb3fb2325e6192a23be04ec763</originalsourceid><addsrcrecordid>eNp9kT1v2zAQhomiQe04_QFdAo1ZpPAokZJaIEBh5AtwkKJJZoKiTg1dmXRJKYD_fajazZCh073D8x5wzxHyBWgGFMT5Omv7NmMU8oyWGQX-gcyhKqs054J9jJnXNK0Er2bkOIQ1pQwEp5_IjBUxshLm5MedsuoXbtAOiesSYzvUg3E2xJho4_2zG4xOtmowEQlfk5-4df4vq5Jl5NCGMUypQ49W4wk56lQf8PNhLsjT1eXj8iZd3V_fLr-vUl1wGNISFFZUFKVqdEO7QomCV1qUdSeQCVGzoi04a9om7xqWM44CaqZY3iAtUJciX5Cz_d6td39GDIPcmKCx75VFNwYJHKCKzTqPKOxR7V0IHju59Waj_E4ClZNIuZZRpJxESlrKKDJ2Tg_rx2aD7Vvjn7kIfNsDGI98Mehl0GYS0BofFcrWmf-uv3jX1r2xRqv-N-4wrN3obbQnQQYmqXyYPjk9EvL4RB7vegVvzpek</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1511823293</pqid></control><display><type>article</type><title>Management of infections in cirrhotic patients: Report of a Consensus Conference</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fagiuoli, Stefano ; Colli, Agostino ; Bruno, Raffaele ; Burra, Patrizia ; Craxì, Antonio ; Gaeta, Giovan Battista ; Grossi, Paolo ; Mondelli, Mario U ; Puoti, Massimo ; Sagnelli, Evangelista ; Stefani, Stefania ; Toniutto, Pierluigi</creator><creatorcontrib>Fagiuoli, Stefano ; Colli, Agostino ; Bruno, Raffaele ; Burra, Patrizia ; Craxì, Antonio ; Gaeta, Giovan Battista ; Grossi, Paolo ; Mondelli, Mario U ; Puoti, Massimo ; Sagnelli, Evangelista ; Stefani, Stefania ; Toniutto, Pierluigi</creatorcontrib><description>Abstract The statements produced by the consensus conference on infection in end-stage liver disease promoted by the Italian Association for the Study of the Liver, are here reported. The topics of epidemiology, risk factors, diagnosis, prophylaxis, and treatment of infections in patient with compensated and decompensated liver cirrhosis were reviewed by a scientific board of experts who proposed 26 statements that were graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. By systematic literature search of available evidence, comparison and discussion of expert opinions, pertinent statements answering specific questions were presented and approved. Short comments were added to explain the basis for grading evidence particularly on case of controversial areas.</description><identifier>ISSN: 1590-8658</identifier><identifier>EISSN: 1878-3562</identifier><identifier>DOI: 10.1016/j.dld.2013.07.015</identifier><identifier>PMID: 24021271</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antifungal Agents - therapeutic use ; Bacterial infection ; Bacterial Infections - complications ; Bacterial Infections - drug therapy ; Cirrhosis ; Evidence-Based Medicine ; Fungal infections ; Gastroenterology and Hepatology ; Humans ; Infections ; Liver Cirrhosis - complications ; Mycoses - complications ; Mycoses - drug therapy</subject><ispartof>Digestive and liver disease, 2014-03, Vol.46 (3), p.204-212</ispartof><rights>The Authors</rights><rights>2013 The Authors</rights><rights>Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-71ae80647abcb0f4a6458c679f6e266924d452bdb3fb2325e6192a23be04ec763</citedby><cites>FETCH-LOGICAL-c451t-71ae80647abcb0f4a6458c679f6e266924d452bdb3fb2325e6192a23be04ec763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dld.2013.07.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,777,781,786,787,3538,23912,23913,25122,27906,27907,45977</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24021271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fagiuoli, Stefano</creatorcontrib><creatorcontrib>Colli, Agostino</creatorcontrib><creatorcontrib>Bruno, Raffaele</creatorcontrib><creatorcontrib>Burra, Patrizia</creatorcontrib><creatorcontrib>Craxì, Antonio</creatorcontrib><creatorcontrib>Gaeta, Giovan Battista</creatorcontrib><creatorcontrib>Grossi, Paolo</creatorcontrib><creatorcontrib>Mondelli, Mario U</creatorcontrib><creatorcontrib>Puoti, Massimo</creatorcontrib><creatorcontrib>Sagnelli, Evangelista</creatorcontrib><creatorcontrib>Stefani, Stefania</creatorcontrib><creatorcontrib>Toniutto, Pierluigi</creatorcontrib><title>Management of infections in cirrhotic patients: Report of a Consensus Conference</title><title>Digestive and liver disease</title><addtitle>Dig Liver Dis</addtitle><description>Abstract The statements produced by the consensus conference on infection in end-stage liver disease promoted by the Italian Association for the Study of the Liver, are here reported. The topics of epidemiology, risk factors, diagnosis, prophylaxis, and treatment of infections in patient with compensated and decompensated liver cirrhosis were reviewed by a scientific board of experts who proposed 26 statements that were graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. By systematic literature search of available evidence, comparison and discussion of expert opinions, pertinent statements answering specific questions were presented and approved. Short comments were added to explain the basis for grading evidence particularly on case of controversial areas.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Bacterial infection</subject><subject>Bacterial Infections - complications</subject><subject>Bacterial Infections - drug therapy</subject><subject>Cirrhosis</subject><subject>Evidence-Based Medicine</subject><subject>Fungal infections</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Infections</subject><subject>Liver Cirrhosis - complications</subject><subject>Mycoses - complications</subject><subject>Mycoses - drug therapy</subject><issn>1590-8658</issn><issn>1878-3562</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kT1v2zAQhomiQe04_QFdAo1ZpPAokZJaIEBh5AtwkKJJZoKiTg1dmXRJKYD_fajazZCh073D8x5wzxHyBWgGFMT5Omv7NmMU8oyWGQX-gcyhKqs054J9jJnXNK0Er2bkOIQ1pQwEp5_IjBUxshLm5MedsuoXbtAOiesSYzvUg3E2xJho4_2zG4xOtmowEQlfk5-4df4vq5Jl5NCGMUypQ49W4wk56lQf8PNhLsjT1eXj8iZd3V_fLr-vUl1wGNISFFZUFKVqdEO7QomCV1qUdSeQCVGzoi04a9om7xqWM44CaqZY3iAtUJciX5Cz_d6td39GDIPcmKCx75VFNwYJHKCKzTqPKOxR7V0IHju59Waj_E4ClZNIuZZRpJxESlrKKDJ2Tg_rx2aD7Vvjn7kIfNsDGI98Mehl0GYS0BofFcrWmf-uv3jX1r2xRqv-N-4wrN3obbQnQQYmqXyYPjk9EvL4RB7vegVvzpek</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Fagiuoli, Stefano</creator><creator>Colli, Agostino</creator><creator>Bruno, Raffaele</creator><creator>Burra, Patrizia</creator><creator>Craxì, Antonio</creator><creator>Gaeta, Giovan Battista</creator><creator>Grossi, Paolo</creator><creator>Mondelli, Mario U</creator><creator>Puoti, Massimo</creator><creator>Sagnelli, Evangelista</creator><creator>Stefani, Stefania</creator><creator>Toniutto, Pierluigi</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>Management of infections in cirrhotic patients: Report of a Consensus Conference</title><author>Fagiuoli, Stefano ; Colli, Agostino ; Bruno, Raffaele ; Burra, Patrizia ; Craxì, Antonio ; Gaeta, Giovan Battista ; Grossi, Paolo ; Mondelli, Mario U ; Puoti, Massimo ; Sagnelli, Evangelista ; Stefani, Stefania ; Toniutto, Pierluigi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-71ae80647abcb0f4a6458c679f6e266924d452bdb3fb2325e6192a23be04ec763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Bacterial infection</topic><topic>Bacterial Infections - complications</topic><topic>Bacterial Infections - drug therapy</topic><topic>Cirrhosis</topic><topic>Evidence-Based Medicine</topic><topic>Fungal infections</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Infections</topic><topic>Liver Cirrhosis - complications</topic><topic>Mycoses - complications</topic><topic>Mycoses - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fagiuoli, Stefano</creatorcontrib><creatorcontrib>Colli, Agostino</creatorcontrib><creatorcontrib>Bruno, Raffaele</creatorcontrib><creatorcontrib>Burra, Patrizia</creatorcontrib><creatorcontrib>Craxì, Antonio</creatorcontrib><creatorcontrib>Gaeta, Giovan Battista</creatorcontrib><creatorcontrib>Grossi, Paolo</creatorcontrib><creatorcontrib>Mondelli, Mario U</creatorcontrib><creatorcontrib>Puoti, Massimo</creatorcontrib><creatorcontrib>Sagnelli, Evangelista</creatorcontrib><creatorcontrib>Stefani, Stefania</creatorcontrib><creatorcontrib>Toniutto, Pierluigi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive and liver disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fagiuoli, Stefano</au><au>Colli, Agostino</au><au>Bruno, Raffaele</au><au>Burra, Patrizia</au><au>Craxì, Antonio</au><au>Gaeta, Giovan Battista</au><au>Grossi, Paolo</au><au>Mondelli, Mario U</au><au>Puoti, Massimo</au><au>Sagnelli, Evangelista</au><au>Stefani, Stefania</au><au>Toniutto, Pierluigi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of infections in cirrhotic patients: Report of a Consensus Conference</atitle><jtitle>Digestive and liver disease</jtitle><addtitle>Dig Liver Dis</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>46</volume><issue>3</issue><spage>204</spage><epage>212</epage><pages>204-212</pages><issn>1590-8658</issn><eissn>1878-3562</eissn><abstract>Abstract The statements produced by the consensus conference on infection in end-stage liver disease promoted by the Italian Association for the Study of the Liver, are here reported. The topics of epidemiology, risk factors, diagnosis, prophylaxis, and treatment of infections in patient with compensated and decompensated liver cirrhosis were reviewed by a scientific board of experts who proposed 26 statements that were graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. By systematic literature search of available evidence, comparison and discussion of expert opinions, pertinent statements answering specific questions were presented and approved. Short comments were added to explain the basis for grading evidence particularly on case of controversial areas.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>24021271</pmid><doi>10.1016/j.dld.2013.07.015</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1590-8658 |
| ispartof | Digestive and liver disease, 2014-03, Vol.46 (3), p.204-212 |
| issn | 1590-8658 1878-3562 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1511823293 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Anti-Bacterial Agents - therapeutic use Antifungal Agents - therapeutic use Bacterial infection Bacterial Infections - complications Bacterial Infections - drug therapy Cirrhosis Evidence-Based Medicine Fungal infections Gastroenterology and Hepatology Humans Infections Liver Cirrhosis - complications Mycoses - complications Mycoses - drug therapy |
| title | Management of infections in cirrhotic patients: Report of a Consensus Conference |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T10%3A13%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20infections%20in%20cirrhotic%20patients:%20Report%20of%20a%20Consensus%20Conference&rft.jtitle=Digestive%20and%20liver%20disease&rft.au=Fagiuoli,%20Stefano&rft.date=2014-03-01&rft.volume=46&rft.issue=3&rft.spage=204&rft.epage=212&rft.pages=204-212&rft.issn=1590-8658&rft.eissn=1878-3562&rft_id=info:doi/10.1016/j.dld.2013.07.015&rft_dat=%3Cproquest_cross%3E1511823293%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1511823293&rft_id=info:pmid/24021271&rft_els_id=S1590865813002582&rfr_iscdi=true |